Company / Book Value per Share
Halozyme Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.396
FY2025
5-year range
$0.396 / $2.87
FY2021-FY2025
Trend
-86.2%
vs FY2024
Sector context
#184 of 209
Health Care
What the data says
Halozyme's book value per share of $0.396 is lower than 88% of companies in the Health Care sector (FY2025). Book Value per Share has fluctuated over the past 10 years, ranging from $0.323 in FY2016 to $2.87 in FY2024.
Based on SEC 10-K filings.
$0.396 in FY2025 with a 5-year CAGR of -26.3%.
Declined from $0.62 to $0.396 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -31.5%
- 5-Year CAGR
- -26.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 209This company $0.396 Sector average $215.686
▼
-99.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -26.3%, indicating a declining trend.
- In FY2025, book value per share decreased 86.2% year-over-year.
- Ranks #184 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2024.
Company context
Key Data Points
- Strong profit margin: 47.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 118.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.396 | -86.2% |
| FY2024 | $2.87 | +362.8% |
| FY2023 | $0.62 | -49.8% |
| FY2022 | $1.235 | +81.7% |
| FY2021 | $0.68 | -62.7% |
| FY2020 | $1.821 | +26.4% |
| FY2019 | $1.44 | -17.4% |
| FY2018 | $1.743 | +8.3% |
| FY2017 | $1.609 | +398.6% |
| FY2016 | $0.323 | +302.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026